{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:05:13Z","timestamp":1770480313242,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T00:00:00Z","timestamp":1311206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T00:00:00Z","timestamp":1311206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/ijir.2011.36","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T08:02:38Z","timestamp":1311235358000},"page":"235-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature"],"prefix":"10.1038","volume":"23","author":[{"given":"E","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"De Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G B","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,21]]},"reference":[{"key":"BFijir201136_CR1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ucl.2007.08.017","volume":"34","author":"FL Taylor","year":"2007","unstructured":"Taylor FL, Levine LA . Peyronie's disease. Urol Clin North Am 2007; 34: 517\u2013534.","journal-title":"Urol Clin North Am"},{"key":"BFijir201136_CR2","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A et al. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171: 2350\u20132353.","journal-title":"J Urol"},{"key":"BFijir201136_CR3","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","volume":"5","author":"CJ Nelson","year":"2008","unstructured":"Nelson CJ, Diblasio C, Kendirci M, hellstrom W, Guhring P, Mulhall JP . The chronology of depression and distress in men with Peyronie's disease. J Sex Med 2008; 5: 1985\u20131990.","journal-title":"J Sex Med"},{"key":"BFijir201136_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0022-5347(05)64129-8","volume":"169","author":"EW Hauck","year":"2003","unstructured":"Hauck EW, Hauptmann A, Schmelz HU, Bein G, Weidner W, Hackstein H . Prospective analysis of single nucleotide polymorphisms of the transforming growth factor \u03b2-1 gene in Peyronie's disease. J Urol 2003; 169: 369\u2013372.","journal-title":"J Urol"},{"key":"BFijir201136_CR5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF . Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997; 158: 1391\u20131394.","journal-title":"J Urol"},{"key":"BFijir201136_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ncpuro0201","volume":"2","author":"NF Gonzalez-Cadavid","year":"2005","unstructured":"Gonzalez-Cadavid NF, Rajfer J . Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease. Nat Clin Pract Urol 2005; 2: 291\u2013297.","journal-title":"Nat Clin Pract Urol"},{"key":"BFijir201136_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","volume":"14","author":"JP Mulhall","year":"2002","unstructured":"Mulhall JP, Anderson MS, Lubrano T, Shankey TV . Peyronie's cell culture model: phenotypic, genotypic and functional analyses. Int J Impot Res 2002; 14: 397\u2013405.","journal-title":"Int J Impot Res"},{"key":"BFijir201136_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chapponier C, Brown RA . Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349\u2013363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFijir201136_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1095\/biolreprod.105.041038","volume":"73","author":"D Vernet","year":"2005","unstructured":"Vernet D, Nolazco G, Cantini L, Magee TR, Qian A, Rajfer J et al. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for Peyronie's disease. Biol Reprod 2005; 73: 1199\u20131210.","journal-title":"Biol Reprod"},{"key":"BFijir201136_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1089-8603(02)00124-6","volume":"7","author":"D Vernet","year":"2002","unstructured":"Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J et al. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 2002; 7: 262\u2013276.","journal-title":"Nitric Oxide"},{"key":"BFijir201136_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.ijir.3901170","volume":"16","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Nicholson B, Pierpaoli S, Lubrano T, Shankey TV . Chromosomal instability is demonstrated by fibroblasts derived from tunica of men with Peyronie's disease. Int J Impot Res 2004; 16: 288\u2013293.","journal-title":"Int J Impot Res"},{"key":"BFijir201136_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1743-6109.2009.01556.x","volume":"7","author":"LX De Young","year":"2010","unstructured":"De Young LX, Bella AJ, O\u2019Gorman DB, Gan BS, Lim KB, Brock GB . Protein biomarker analysis of primary Peyronie's disease cells. J Sex Med 2010; 7: 99\u2013106.","journal-title":"J Sex Med"},{"key":"BFijir201136_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0090-4295(01)01578-3","volume":"59","author":"TR Magee","year":"2002","unstructured":"Magee TR, Qian A, Rajfer J, Sander FC, Levine LA, Gonzalez-Cadavid NF . Gene expression profiles in the Peyronie's disease plaque. Urology 2002; 59: 451\u2013457.","journal-title":"Urology"},{"key":"BFijir201136_CR14","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI, Hassoba HM, Chui RM, Bhatnagar RS, Dahiya R, Lue TF . An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 1997; 158: 2284\u20132290.","journal-title":"J Urol"},{"key":"BFijir201136_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0898-6568(02)00058-X","volume":"14","author":"M Lutz","year":"2002","unstructured":"Lutz M, Knaus P . Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 2002; 14: 977\u2013988.","journal-title":"Cell Signal"},{"key":"BFijir201136_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.eururo.2006.05.002","volume":"51","author":"SM Haag","year":"2007","unstructured":"Haag SM, Hauck EW, Szardening-Kirchner C, Diemer T, Cha ES, Weidner W et al. Alterations in the transforming growth factor (TGF)-\u03b2 pathway as a potential factor in the pathogenesis of Peyronie's disease. Eur Urol 2007; 51: 255\u2013261.","journal-title":"Eur Urol"},{"key":"BFijir201136_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI115821","volume":"90","author":"WA Border","year":"1992","unstructured":"Border WA, Ruoslahti E . Transforming growth factor beta in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1\u20137.","journal-title":"J Clin Invest"},{"key":"BFijir201136_CR18","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/S0022-5347(05)67616-1","volume":"163","author":"TJ Bivalacqua","year":"2000","unstructured":"Bivalacqua TJ, Diner EK, Novak TE, Vohra Y, Sikka SC, Champion HC et al. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric-oxide synthase protein expression. J Urol 2000; 163: 1992\u20131998.","journal-title":"J Urol"},{"key":"BFijir201136_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1006\/niox.2001.0421","volume":"6","author":"MG Ferrini","year":"2002","unstructured":"Ferrini MG, Vernet D, Magee TR, Shahed A, Qian A, Rajfer J et al. Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide 2002; 6: 283\u2013294.","journal-title":"Nitric Oxide"},{"key":"BFijir201136_CR20","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/j.1743-6109.2008.00847.x","volume":"5","author":"LP Cantini","year":"2008","unstructured":"Cantini LP, Ferrini MG, Vernet D, Magee TR, Qian A, Gelfand RA et al. Profibrotic role of myostatin in Peyronie's disease. J Sex Med 2008; 5: 1607\u20131622.","journal-title":"J Sex Med"},{"key":"BFijir201136_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1677\/JOE-07-0408","volume":"196","author":"J Artaza","year":"2008","unstructured":"Artaza J, Singh R, Ferrini MG, Braga M, Tsao J, Gonzalez-Cadavid NF . Myostatin promotes a fibrotic phenotypic switch in multipotent C3H10T1\/1 cells without affecting their differentiation into myofibroblasts. J Endocrinol 2008; 196: 235\u2013249.","journal-title":"J Endocrinol"},{"key":"BFijir201136_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1464-410X.2006.05955.x","volume":"97","author":"MG Ferrini","year":"2006","unstructured":"Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF . Effects of long-term treatment with vardenafil on the development of the fibrotic plaque model in rat model of Peyronie's disease. BJU Int 2006; 97: 625\u2013633.","journal-title":"BJU Int"},{"key":"BFijir201136_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","volume":"9","author":"EG Valente","year":"2003","unstructured":"Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF . L-arginine and PDE inhibitors counteract fibrosis in Peyronie's plaque and related fibroblast cultures. Nitric Oxide 2003; 9: 229\u2013244.","journal-title":"Nitric Oxide"},{"key":"BFijir201136_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1165\/rcmb.2002-0249OC","volume":"30","author":"FQ Wen","year":"2004","unstructured":"Wen FQ, Liu X, Kobayashi T, Abe S, Fang Q, Kohyama T et al. Interferon-gamma inhibits transforming growth factor-beta production in human epithelial cells by targeting Smads. Am J Respir Cell Mol Biol 2004; 30: 816\u2013822.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFijir201136_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","volume":"176","author":"WJ Hellstrom","year":"2006","unstructured":"Hellstrom WJ, Kendirci M, Matern R, Cockerham Y, Myers L, Sikka SC et al. Single-blind, mulicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease. J Urol 2006; 176: 394\u2013398.","journal-title":"J Urol"},{"key":"BFijir201136_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2605.2007.00780.x","volume":"31","author":"S Piao","year":"2007","unstructured":"Piao S, Ryu JK, Shin HY, Zhang L, Song SU, Han JY et al. Repeated intratunical injection of adenovirus expressing transforming growth factor-beta 1 in rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease. Int J Androl 2007; 31: 346\u2013353.","journal-title":"Int J Androl"},{"key":"BFijir201136_CR27","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","volume":"3","author":"MW Mosesson","year":"2005","unstructured":"Mosesson MW . Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894\u20131904.","journal-title":"J Thromb Haemost"},{"key":"BFijir201136_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0022-5347(17)53917-8","volume":"127","author":"KD Somers","year":"1982","unstructured":"Somers KD, Dawson DM, Wright Jr GL, Leffell MS, Rowe MJ, Bluemink GG et al. Cell culture of Peyronie's disease plaque and normal penile tissue. J Urol 1982; 127: 585\u2013588.","journal-title":"J Urol"},{"key":"BFijir201136_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0022-5347(01)65367-9","volume":"157","author":"KD Somers","year":"1997","unstructured":"Somers KD, Dawson DM . Fibrin deposition in Peyronie's disease plaque. J Urol 1997; 157: 311\u2013315.","journal-title":"J Urol"},{"key":"BFijir201136_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0266-7681(86)90013-6","volume":"11","author":"G Merlo","year":"1986","unstructured":"Merlo G, Ambroggio GP, Castagna B, Mosca A, Oberto E . Fibrin\/fibrinogen and fibronolytic activity of the palmar fascia in Dupuytren's contracture. J Hand Surg 1986; 11: 55\u201357.","journal-title":"J Hand Surg"},{"key":"BFijir201136_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0022-5347(17)44170-X","volume":"137","author":"KD Somers","year":"1987","unstructured":"Somers KD, Winters BM, Dawson DM, Leffell MS, Wright Jr GL, Devine Jr CJ et al. Chromosomal abnormalities in Peyronie's disease. J Urol 1987; 137: 672\u2013675.","journal-title":"J Urol"},{"key":"BFijir201136_CR32","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1046\/j.1464-410X.2003.04224.x","volume":"91","author":"HH Davila","year":"2003","unstructured":"Davila HH, Ferrini MG, Rajfer J, Gonzalez-Cadavid NF . Fibrin as an inducer of fibrosis in the tunica albuginea of rat: a new animal model of Peyronie's disease. BJU Int 2003; 91: 830\u2013838.","journal-title":"BJU Int"},{"key":"BFijir201136_CR33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.urology.2005.01.010","volume":"65","author":"HH Davila","year":"2005","unstructured":"Davila HH, Magee TR, Zuniga FI, Rajfer J, Gonzalez-Cadavid NF . Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque. Urology 2005; 65: 645\u2013648.","journal-title":"Urology"},{"key":"BFijir201136_CR34","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1097\/00005392-199805000-00097","volume":"159","author":"AI El-Sakka","year":"1998","unstructured":"El-Sakka AI, Selph CA, Yen TS, Dahiya R, Lue TF . The effect of surgical trauma on rat tunica albuginea. J Urol 1998; 159: 1700\u20131707.","journal-title":"J Urol"},{"key":"BFijir201136_CR35","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.biocel.2008.05.012","volume":"40","author":"M Lucattelli","year":"2008","unstructured":"Lucattelli M, Lunghi B, Fineshi S, Mirone V, d\u2019Emmanuele di Villa Bianca R, Longo N et al. A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. Int J Biochem Cell Biol 2008; 40: 2638\u20132648.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFijir201136_CR36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.bor.0000245719.64393.57","volume":"18","author":"R Lemaire","year":"2006","unstructured":"Lemaire R, Bayle J, Lafyatis R . Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor beta regulation and systemic sclerosis. Curr Opin Rheumatol 2006; 18: 582\u2013587.","journal-title":"Curr Opin Rheumatol"},{"key":"BFijir201136_CR37","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.juro.2008.01.093","volume":"179","author":"M Del Carlo","year":"2008","unstructured":"Del Carlo M, Cole AA, Levine LA . Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukins-1\u03b2 and transforming growth factor-\u03b2 in Peyronie's plaque fibroblasts. J Urol 2008; 179: 2447\u20132455.","journal-title":"J Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijir201136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:12:32Z","timestamp":1648653152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijir201136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,21]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFijir201136"],"URL":"https:\/\/doi.org\/10.1038\/ijir.2011.36","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,21]]},"assertion":[{"value":"9 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}